Vanguard Capital Management’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.21M Buy
288,610
+10,420
+4% +$174K ﹤0.01% 3067
2026
Q2
$6.53M Sell
278,190
-20,076
-7% -$488K ﹤0.01% 3020
2026
Q1
$7.16M Buy
+298,266
New +$7.78M ﹤0.01% 2904

Other funds holding GLSI

Vanguard Capital Management's GLSI Position: Q3 2026 in Review

Vanguard Capital Management increased its Greenwich LifeSciences (GLSI) stake by 3.7% in Q3 2026, buying an estimated $174K and bringing the position to 288,610 shares worth $5.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

Vanguard Capital Management first reported a position in GLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.16M in Q1 2026. 42 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • Vanguard Capital Management held 288,610 shares of Greenwich LifeSciences worth $5.21M as of Q3 2026.
  • Vanguard Capital Management bought 10,420 Greenwich LifeSciences shares in Q3 2026, an estimated $174K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3067 holding.
  • Vanguard Capital Management first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Greenwich LifeSciences position peaked at $7.16M in Q1 2026.
  • 42 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.